niclosamide has been researched along with Kidney Neoplasms in 2 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
Kidney Neoplasms: Tumors or cancers of the KIDNEY.
Excerpt | Relevance | Reference |
---|---|---|
"As the most lethal urological cancers, renal cell carcinoma (RCC) comprises a heterogeneous group of cancer with diverse genetic and molecular alterations." | 1.48 | Niclosamide Exhibits Potent Anticancer Activity and Synergizes with Sorafenib in Human Renal Cell Cancer Cells. ( An, L; Chen, L; Dai, Z; Feng, Y; Gan, H; Gong, C; Haydon, RC; He, F; He, TC; Huang, B; Huang, S; Ji, X; Lei, J; Liu, B; Liu, F; Liu, W; Luu, HH; Shu, Y; Wang, X; Wu, K; Wu, X; Wu, Y; Yan, S; Yang, C; Yu, X; Yuan, C; Zeng, L; Zeng, Z; Zhang, B; Zhang, L; Zhang, R; Zhang, W; Zhao, C, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yu, X | 1 |
Liu, F | 1 |
Zeng, L | 1 |
He, F | 1 |
Zhang, R | 1 |
Yan, S | 1 |
Zeng, Z | 1 |
Shu, Y | 1 |
Zhao, C | 1 |
Wu, X | 1 |
Lei, J | 1 |
Zhang, W | 1 |
Yang, C | 1 |
Wu, K | 1 |
Wu, Y | 1 |
An, L | 1 |
Huang, S | 1 |
Ji, X | 1 |
Gong, C | 1 |
Yuan, C | 1 |
Zhang, L | 1 |
Feng, Y | 1 |
Huang, B | 1 |
Liu, W | 1 |
Zhang, B | 1 |
Dai, Z | 1 |
Wang, X | 1 |
Liu, B | 1 |
Haydon, RC | 1 |
Luu, HH | 1 |
Gan, H | 1 |
He, TC | 1 |
Chen, L | 1 |
Yun, JM | 1 |
Woo, SM | 1 |
Seo, SU | 1 |
Min, KJ | 1 |
Kim, DE | 1 |
Kwon, TK | 1 |
2 other studies available for niclosamide and Kidney Neoplasms
Article | Year |
---|---|
Niclosamide Exhibits Potent Anticancer Activity and Synergizes with Sorafenib in Human Renal Cell Cancer Cells.
Topics: Carcinoma, Renal Cell; Cell Cycle; Drug Synergism; Gene Expression Regulation, Enzymologic; Gene Exp | 2018 |
Involvement of Up-Regulation of DR5 Expression and Down-Regulation of c-FLIP in Niclosamide-Mediated TRAIL Sensitization in Human Renal Carcinoma Caki Cells.
Topics: Apoptosis; Carcinoma, Renal Cell; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor | 2018 |